Key result
Bioengineered human biatrial tissue model enables light-controlled arrhythmia modeling and drug testing.
Why the study?
The study of atrial arrhythmias has been limited by the lack of anatomically relevant human cardiac tissue models and inability to perform targeted functional perturbations.
Answers are grounded in this paper and cite their sources.
A novel light-controllable bioengineered humanized biatrial tissue model was successfully established, providing a new platform for studying atrial arrhythmias, biological pacemakers, and optogenetic therapies.
BACKGROUND: The study of atrial arrhythmias has been hampered by the lack of anatomically relevant human cardiac tissue models and by the inability to perform targeted, functional perturbations in such models. METHODS: To engineer anatomically relevant light-sensitive atrial chambers, we combined human pluripotent stem cells, differentiation protocols yielding atrial and sinoatrial nodal cells, rat heart decellularization/recellularization processes, and optogenetics tools. RESULTS: Immunostaining for chamber-specific cardiomyocyte markers, optical action potential recordings, and the response to atrial-specific pharmacology confirmed the atrial-specific identity of the recellularized engineered tissue. Histological examination verified the preservation of the macroscopic and microscopic atrial architecture of the engineered atria. Optical mapping showed the ability of seeded human pluripotent stem cell–derived sinoatrial nodal cells at the correct anatomic site to serve as a biological pacemaker. Adenoviral transduction and transgenic human pluripotent stem cells were used to express the light-sensitive channels, ChR2 (channelrhodopsin-2) or CoChR ( chloromonas oogama channelrhodopsin), in the bioengineered atria, allowing optogenetic pacing and programmed stimulation. Reentrant arrhythmias could be induced and optically mapped in the bioengineered atrial tissue models, demonstrating the ability to recapitulate and provide insights into different atrial fibrillation mechanisms. These arrhythmias could be terminated by localized (focal or linear) or diffused optogenetic silencing (optogenetic cardioversion). CONCLUSIONS: A novel, light-controllable, bioengineered humanized biatrial tissue model was established and could be used to model different atrial arrhythmias, for drug testing, for disease modeling, and for evaluation of novel therapeutic interventions such as biological pacemaking and optogenetic interventions.
No takes yet. Share an insight, caveat, or question.
Ghiringhelli et al. (2026) studied Atrial arrhythmias. Recellularized humanized bioengineered biatrial model with optogenetics was evaluated on Development and functional validation of a bioengineered biatrial tissue model. A novel, light-controllable, bioengineered humanized biatrial tissue model was successfully established to recapitulate atrial fibrillation mechanisms and demonstrate optogenetic cardioversion.
Synapse has enriched 10 related papers. Consider them for comparative context: